Want to see IN:JLHL full AI Analyst Report?
Top Page
Jupiter Life Line Hospitals Ltd.
(JLHL)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹280.00
▼(-4.45% Downside)
Action:Reiterated
Date:07/25/26
The score is primarily driven by improved fundamentals—strong growth, sustained profitability, and a healthier balance sheet—partly offset by materially negative free cash flow and some margin compression. Technically, the trend is positive but very overbought, increasing near-term volatility risk. Valuation is the largest drag due to a high P/E and low dividend yield.
Positive Factors
Consistent Revenue Scaling
Sustained revenue expansion indicates that Jupiter is broadening its hospital activity and maintaining demand across its healthcare offering. Continued growth provides a stronger base for operating leverage, supports investment in clinical capacity, and can reinforce the brand’s position over the next several quarters.
Negative Factors
Negative Free Cash Flow
Weak cash generation after reinvestment is a material constraint for a hospital operator that requires ongoing investment in facilities and equipment. If negative free cash flow persists, Jupiter may have less flexibility to fund expansion internally and could face greater reliance on additional financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Scaling
Sustained revenue expansion indicates that Jupiter is broadening its hospital activity and maintaining demand across its healthcare offering. Continued growth provides a stronger base for operating leverage, supports investment in clinical capacity, and can reinforce the brand’s position over the next several quarters.
Read all positive factors
Jupiter Life Line Hospitals Ltd. (JLHL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹85.71B
Dividend Yield0.08%
Average Volume (3M)66.39K
Price to Earnings (P/E)44.3
Beta (1Y)0.18
Revenue Growth18.23%
EPS Growth-2.62%
CountryIN
Employees3,002
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)5.72
Shares Outstanding327,830,100
10 Day Avg. Volume62,443
30 Day Avg. Volume66,395
Financial Highlights & Ratios
PEG Ratio84.98
Price to Book (P/B)5.45
Price to Sales (P/S)5.61
P/FCF Ratio-35.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.85
Revenue Forecast (FY)₹17.95B
Jupiter Life Line Hospitals Ltd. Business Overview & Revenue Model
Company Description
Jupiter Life Line Hospitals Limited, established in Mumbai, India, in 2002, operates as a multi-specialty healthcare provider throughout the country under its Jupiter brand. The company delivers a comprehensive range of medical and surgical servic...
How the Company Makes Money
JLHL primarily makes money by delivering hospital-based clinical care to patients and charging for healthcare services provided through its facilities. Key revenue streams typically include: (1) Inpatient services: fees related to hospital admissi...
Jupiter Life Line Hospitals Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
72
Positive
Cash Flow
56
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.58B | 15.00B | 12.62B | 10.70B | 8.93B | 7.33B |
| Gross Profit | 9.84B | 8.69B | 10.31B | 8.55B | 7.11B | 4.07B |
| EBITDA | 3.69B | 3.43B | 3.25B | 2.61B | 2.06B | 1.50B |
| Net Income | 1.88B | 1.94B | 1.93B | 1.77B | 729.05M | 511.28M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 23.83B | 19.05B | 12.81B | 9.86B | 9.09B |
| Cash, Cash Equivalents and Short-Term Investments | 5.40B | 5.44B | 6.03B | 3.18B | 1.36B | 1.06B |
| Total Debt | 0.00 | 5.84B | 3.93B | 623.41M | 4.69B | 4.95B |
| Total Liabilities | -15.44B | 8.39B | 5.49B | 1.13B | 6.22B | 6.20B |
| Stockholders Equity | 15.44B | 15.44B | 13.56B | 11.69B | 3.66B | 2.94B |
Cash Flow | ||||||
| Free Cash Flow | -403.95M | -2.34B | -674.22M | 292.26M | 399.24M | 452.40M |
| Operating Cash Flow | 1.30B | 2.68B | 2.53B | 1.15B | 1.17B | 1.37B |
| Investing Cash Flow | -1.73B | -4.65B | -2.09B | -758.89M | -1.04B | -852.46M |
| Financing Cash Flow | -231.75M | 1.60B | 3.01B | 1.28B | 175.00M | 322.02M |
Jupiter Life Line Hospitals Ltd. Technical Analysis
Negative
293.05
Price Trends
299.55
Negative
287.53
Negative
273.37
Negative
Market Momentum
-10.36
Positive
19.88
Positive
14.78
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JLHL, the sentiment is Negative. The current price of 293.05 is above the 20-day moving average (MA) of 276.25, below the 50-day MA of 299.55, and above the 200-day MA of 273.37, indicating a bearish trend. The MACD of -10.36 indicates Positive momentum. The RSI at 19.88 is Positive, neither overbought nor oversold. The STOCH value of 14.78 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JLHL.
Jupiter Life Line Hospitals Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹32.54B | 17.01 | ― | 1.15% | 10.92% | 12.12% | |
70 Outperform | ₹58.00B | 45.23 | ― | 0.13% | 14.96% | 20.76% | |
64 Neutral | ₹85.71B | 44.34 | ― | 0.08% | 18.23% | -2.62% | |
63 Neutral | ₹104.73B | 426.96 | ― | ― | 13.65% | -40.97% | |
62 Neutral | ₹106.53B | 54.92 | ― | 0.05% | 44.00% | 24.10% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | ₹15.34B | 39.17 | ― | 0.44% | 6.50% | ― |
* General Sector Average
IN:JLHL
Jupiter Life Line Hospitals Ltd.
253.45
-45.87
-15.33%
IN:ARTEMISMED
Artemis Medicare Services Ltd.
345.70
111.35
47.51%
IN:HCG
HealthCare Global Enterprises Ltd.
665.95
20.19
3.13%
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
349.05
-101.88
-22.59%
IN:SHALBY
Shalby Ltd.
139.05
-125.70
-47.48%
IN:YATHARTH
Yatharth Hospital and Trauma Care Services Limited
1,033.95
284.34
37.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.